United Orthopedic Corporation (4129.TWO)

TWD 82.6

(-9.92%)

Market Cap (In TWD)

7.95 Billion

Revenue (In TWD)

3.94 Billion

Net Income (In TWD)

384.2 Million

Avg. Volume

165.04 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
82.4-114.0
PE
17.43
EPS
4.74
Beta Value
0.656
ISIN
TW0004129002
CUSIP
-
CIK
-
Shares
96294300.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Healthcare
CEO
Lin Terchien
Employee Count
-
Website
https://www.unitedorthopedic.com
Ipo Date
2007-12-31
Details
United Orthopedic Corporation engages in the research, development, manufacture, and sale of orthopedic implants and surgical instruments. The company offers artificial hip joints, partial hip joints, joints for large trochanteric fracture, Moore hip prosthesis, and customized artificial hip joints for individual tumor patients; artificial knee joint, such as artificial knee replacement joint, revision knee replacement system, restricted artificial knee joints, and customized artificial knee joints for individual tumor patients; and spine products consisting of vertebral fixation devices. It also provides injury and other orthopedic products comprise orthopedic internal fixation, bone plates, bone nails, bone pins, and bone screws; OEM products, such as orthopedic internal fixation; and lamb salvage systems. In addition, the company offers orthopedic surgical equipment and its manufacturing equipment; and special metal and plastic materials, as well as imports and exports its products. It serves in Taiwan, Asia, the Americas, Europe, Africa, and Australia. The company was incorporated in 1993 and is headquartered in New Taipei City, Taiwan. United Orthopedic Corporation is a subsidiary of Chi-Yi Investment Co. Ltd.